SCHEMBL4883680

SCHEMBL4883680

Cc1cccc(Oc2c[nH]nc2-c2cc(Br)c(O)cc2O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 3/20 0.42
ALDH1A1 P00352 3/20 0.39
GAA P10253 2/20 0.39
LYN P07948 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
IDO1 P14902 1/20 0.36
KMT2A Q03164 3/20 0.35
MAPT P10636 4/20 0.34
LMNA P02545 3/20 0.34
TSHR P16473 3/20 0.34
MEN1 O00255 2/20 0.34
ALOX15 P16050 2/20 0.34
AR P10275 1/20 0.34
USP2 O75604 1/20 0.34
TP53 P04637 1/20 0.34
ALOX12 P18054 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ACHE P22303 1/20 0.33
XDH P47989 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4881093 0.89 HSP90AA1 (0.44) HSP90AA1ALDH1A1MAPTNPSR1SMN1; SMN2
SCHEMBL4883681 0.85 SLC6A4 (0.38) HSP90AA1LMNAXDHSLC22A12
SCHEMBL4884695 0.85 F10 (0.38) HSP90AA1ALDH1A1KMT2AMAPTLMNA
SCHEMBL4880403 0.85 HSP90AA1 (0.38) HSP90AA1ALDH1A1KMT2AMAPTLMNA
SCHEMBL4879457 0.84 HSP90AA1 (0.46) HSP90AA1ALDH1A1GAAL3MBTL1KMT2A
SCHEMBL4884200 0.82 MAPT (0.49) HSP90AA1ALDH1A1GAALYNL3MBTL1
SCHEMBL4881078 0.81 HSP90AA1 (0.40) HSP90AA1GAAMAPTLMNATP53
SCHEMBL4884673 0.81 HSP90AA1 (0.40) HSP90AA1KMT2AMAPTLMNATSHR
SCHEMBL4876588 0.81 HSP90AA1 (0.40) HSP90AA1ALDH1A1L3MBTL1KMT2AMAPT
SCHEMBL4873473 0.80 HSP90AA1 (0.41) HSP90AA1ALDH1A1KMT2AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799649-B1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2014-06-25 EP claimed
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US claimed
EP-1799649-B1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2014-06-25 EP disclosed
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2008-04-17 US disclosed
EP-1799649-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS Merck Patent GmbH (DE) 2007-06-27 EP disclosed
WO-2006039977-A1 3-(2-HYDROXYPHENYL) PYRAZOLES AND THEIR USE AS HSP90 MODULATORS MERCK PATENT GMBH (DE) 2006-04-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090880-A1 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators HSP90AB1, HSP90AA1, HSP90AB2P HSP90AA1 2/4885ALDH1A1 1963/4885GAA 1769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.